Haleon HLN
NYSE HLN
$9.90 +0.03 (+0.25%)
At close: Aug 20, 2026 · 12:52 PM UTC

Haleon (HLN) EBIT Growth (3y) (2025)

Haleon (HLN) EBIT Growth (3y) (2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBIT Growth (3y) (Qtr)
1 Haleon 43.98 Bn 43.02 Bn - -
2 Teva Pharmaceutical Industries 43.28 Bn 39.62 Bn 2.15 Bn 29.31%
3 Zoetis 31.78 Bn 30.11 Bn 1.05 Bn 4.24%
4 Takeda Pharmaceutical 28.71 Bn 22.91 Bn 5.10 Bn 0.90%
5 United Therapeutics 22.25 Bn 19.59 Bn 683.80 Mn 1.82%
6 Viatris 18.72 Bn 17.83 Bn 1.46 Bn -74.25%
7 Neurocrine Biosciences 15.57 Bn 15.18 Bn 935.80 Mn 27.21%
8 Elanco Animal Health 11.87 Bn 11.34 Bn 798.00 Mn 35.42%
9 Dr Reddys Laboratories 10.14 Bn 9.97 Bn - -
10 Alkermes 8.14 Bn 7.48 Bn 397.90 Mn -59.74%

Historic Data

Download Data
DateValue
Dec 31, 2025 -2.20%